CSTL Valuation

Castle Biosciences Inc

Add to Watchlist

Advanced Chart

16.540

-0.85(-4.888%)1D

Overview
Forecast
Valuation
Earnings

CSTL Relative Valuation

CSTL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CSTL is overvalued; if below, it's undervalued.

Historical Valuation

Castle Biosciences Inc (CSTL) is now in the Fair zone, suggesting that its current forward PS ratio of 1.83 is considered Fairly compared with the five-year average of -31.10. The fair price of Castle Biosciences Inc (CSTL) is between 11.31 to 102.86 according to relative valuation methord.

Relative Value

Fair Zone

11.31-102.86

Current Price：16.54

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.08

P/B

Median3y

1.51

Median5y

2.47

8.32

FCF Yield

Median3y

-2.83

Median5y

-2.20

Competitors Valuation Multiple

The average P/S ratio for CSTL's competitors is 2.81, providing a benchmark for relative valuation. Castle Biosciences Inc Corp (CSTL) exhibits a P/S ratio of 1.83, which is -34.98% above the industry average. Given its robust revenue growth of 20.57%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

CSTL.O

Castle Biosciences Inc

1.83

Average P/S: 2.81

20.57%